Pay in 4 interest-free payments of $5.13 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
D50.0 applies when chronic blood loss is the documented cause
Loading phase: For patients without neurological involvement, the standard regimen is 1 mg hydroxocobalamin intramuscularly three times weekly for two weeks (total of six injections)
About 5-Amino-1MQ in research Researchers use 5-Amino-1MQ to study NNMT-related pathway activity, NAD+-linked metabolic signalling, and downstream biochemical readouts in cell-based and enzyme-focused systems
Its substrate site-targeting mechanism inhibiting NNMT at the nicotinamide binding site provides selectivity over related methyltransferases and other enzymes in the NAD salvage pathway, making it a precise tool compound for studying NNMT-specific enzymatic activity in controlled laboratory systems
